RedHill Biopharma Ltd.
Pharmaceutical company · Tel Aviv, Israel · Nasdaq: RDHL
RedHill Biopharma Ltd. is a pharmaceutical company headquartered in Tel Aviv, Israel. Its earliest recorded incorporation is in 2009. Its shares trade on Nasdaq under the ticker RDHL. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2024.
RedHill Biopharma at a glance
What does RedHill Biopharma do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $10 million sold (2024).
Frequently asked questions about RedHill Biopharma
Where is RedHill Biopharma headquartered?
RedHill Biopharma Ltd. is headquartered in Tel Aviv, Israel.
What does RedHill Biopharma do?
RedHill Biopharma Ltd. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is RedHill Biopharma a public company?
Yes. RedHill Biopharma Ltd. trades on Nasdaq under the ticker RDHL.
When was RedHill Biopharma founded?
The earliest incorporation on record for RedHill Biopharma Ltd. is in 2009, according to public company registers.
Similar companies
- Chemomab Therapeutics Ltd.Tel Aviv, Israel
- Nasus Pharma LtdTel Aviv, Israel
- UroGen Pharma Ltd.Ra'anana, Central District, Israel
- MediWound Ltd.Yavné, Central District, Israel
- Can-Fite BioPharma Ltd.Ramat Gan, Tel Aviv, Israel
- NeuroSense Therapeutics Ltd.Herzliya, Tel Aviv, Israel
- BioLineRx Ltd.Modi‘in Makkabbim Re‘ut, Central District, Israel
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.